Recent Finacing
Recent Raise
Ocera Therapeutics develops and commercializes AST-120, a spherical adsorbent carbon, conducting Phase 3 trials in fistulizing Crohn's disease, Phase 2 pouchitis trials and proof‑of‑concept GI and liver studies.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors